医学
外科
关节置换术
固定(群体遗传学)
随机对照试验
射线照相术
股骨颈
共病
髋关节置换术
股骨骨折
全髋关节置换术
临床试验
内固定
作者
Julius A. Bishop,Lawrence Henry Goodnough
标识
DOI:10.2106/jbjs.26.00939
摘要
The valgus-impacted femoral neck fracture is unique among hip fractures. Patients are often relatively comfortable, and the fracture pattern is inherently more stable than other femoral neck fracture types. In situ fixation remains the default treatment for most surgeons, and this remains a reasonable approach, particularly for patients unable to reliably protect their weight-bearing. However, multiple randomized controlled trials and meta-analyses have revealed that, when surgery is chosen, arthroplasty carries a lower risk of reoperation and implant-related complications than fixation, with no difference in mortality. Additionally, nonoperative management has achieved rates of uneventful healing comparable with those of fixation in appropriately selected patients who were able to protect their weight-bearing, and delayed arthroplasty after failed nonoperative treatment has not been associated with excess morbidity compared with acute arthroplasty across measured outcomes. Given that fixation in situ may not have dramatically better efficacy than nonoperative care and that failed nonoperative management can be salvaged with delayed arthroplasty without excess morbidity, we propose that nonoperative management is a reasonable initial treatment for select patients. The best candidates are patients who are cognitively intact, living independently, and medically stable and who are reasonably comfortable and capable of mobilizing while protecting their weight-bearing. Close clinical and radiographic follow-up is required, with a low threshold for conversion to arthroplasty in the setting of uncontrolled pain, poor mobilization, or radiographic evidence of loss of reduction. Dementia, high comorbidity burden, and assisted living status are associated with failure of nonoperative management. In all circumstances, both fixation and acute arthroplasty remain valid alternative strategies. We advocate a shared decision-making approach that accounts for the risks and benefits of all treatment strategies as well as patient factors.
科研通智能强力驱动
Strongly Powered by AbleSci AI